Document is current
Any future updates will be listed below
-
Authors
Kumar, Durgesh
Gaikwad, Kshitij
Gunnale, Rushank
Vishwakarma, Sandeep
Shukla, Shalu
Srivastava, Shalini
Gopal, Janhavi
Vaidya, Bhalchandra
Saraf, Amit
Gurjar, Rohan
Kaviraj, Swarnendu
Singh, Ajay
Raghuwanshi, Arjun
Agarwal, Praveen
Savergave, Laxman
Singh, Sanjay
,
-
Funding
Funding for this research was provided by:
Authors is supported by an internal industry-based salary structure.
Funded by Gennova Biopharmaceuticals Limited for their contribution to this study
- License Information
-
More Information
Article History
Received: 17 August 2024
Accepted: 16 January 2025
First Online: 1 March 2025
Competing interests
: The authors declare no duality of interest associated with this manuscript. All authors were supported by the internal organization’s salary structure. Gennova Biopharmaceuticals Limited. Dr Himanshu Shashikant Pophale, Dr Prakash Sadashiv Shende, Dr Ravindra Shinde, Dr Vikram B Vikhe, Dr Abhishek Madhav Karmalkar, Dr Bhaskar Vilasrao Jedhe-Deshmukh, Dr Krishna Madhukar Giri, Dr Shrikant Vishnu Deshpande, Dr Ajay Abhimanyu Bulle, Dr Mohammed Sabah Siddiqui, Dr Swapnav Borthakur, Dr V Reddy Tummuru, Dr A. Venkateshwar Rao, Dr Dhaiwat Murugesh Shukla, Dr Manish Kumar Jain, Dr Pankaj Bhardwaj, Dr Pravin Dinkar Supe, Dr Manoj K Das, Dr Vijay Kumar Bhagwan Barge, and Dr Manoj Lahoti were clinical trial site investigators who were funded by Gennova Biopharmaceuticals Limited for their contribution to this study.
